Moreover, the genetic inhibition of IRE1α-XBP1 axis was performed by RNA interference technique and further demonstrate that inhibiting IRE1α signaling might have therapeutic potential for AD by mediating the recovery of mitochondrial functions. The gene discussed is XBP1; the disease is Alzheimer disease.